Sol-Gel Technologies (SLGL) Operating Expenses (2017 - 2026)

Sol-Gel Technologies' (SLGL) quarterly Operating Expenses came in at $4.0 million in Q1 2026, down 60.76% year-on-year from $10.1 million in Q1 2025, and down 4.76% on a QoQ basis from $4.2 million in Q4 2025.

Sol-Gel Technologies (SLGL) Operating Expenses (2017 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has 10 years of Operating Expenses data on file, last reported at $4.0 million in Q1 2026.

  • On a quarterly basis, Operating Expenses fell 60.76% year-over-year to $4.0 million in Q1 2026; TTM through Mar 2026 was $20.8 million, a 21.27% decrease from a year earlier, with the FY2025 full-year figure at $27.0 million, up 14.56% from the prior year.
  • Operating Expenses for Q1 2026 stood at $4.0 million, down from $4.2 million in the prior quarter.
  • Over the last five years, Operating Expenses for SLGL reached as high as $11.4 million in Q1 2023 and fell as low as $3.8 million in Q2 2024.
  • Historically, Operating Expenses has averaged $6.2 million across 5 years, with a median of $6.2 million in 2024.
  • Across the five-year window, Operating Expenses soared 90.88% in 2023 and sank 60.76% in 2026, its largest moves.
  • Year by year, Operating Expenses stood at $6.3 million in 2022, then dropped by 6.5% to $5.9 million in 2023, then gained by 8.18% to $6.4 million in 2024, then tumbled by 34.75% to $4.2 million in 2025, then retreated by 4.76% to $4.0 million in 2026.
  • Per Business Quant data, the three most recent Operating Expenses figures were $4.0 million in Q1 2026, $4.2 million in Q4 2025, and $6.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -28.01 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 15.76 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.10 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.85 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 2.96 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 32.68 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -919.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 445.22 Mn
10 Sol-Gel Technologies 234.04 Mn 223.91 Mn - 3.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.96 Mn
Dec 31, 2025 4.16 Mn
Sep 30, 2025 6.69 Mn
Jun 30, 2025 6.03 Mn
Mar 31, 2025 10.10 Mn
Dec 31, 2024 6.38 Mn
Sep 30, 2024 6.19 Mn
Jun 30, 2024 3.81 Mn
Mar 31, 2024 7.18 Mn
Dec 31, 2023 5.90 Mn
Sep 30, 2023 6.53 Mn
Jun 30, 2023 7.12 Mn
Mar 31, 2023 11.36 Mn
Dec 31, 2022 6.31 Mn
Sep 30, 2022 3.89 Mn
Jun 30, 2022 3.98 Mn
Mar 31, 2022 5.95 Mn
Dec 31, 2021 6.82 Mn
Sep 30, 2021 8.12 Mn
Jun 30, 2021 8.97 Mn